Gabanan, Dan B.

HRN: 25-85-73  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/15/2024
CO-AMOXICLAV 625MG (TAB)
09/15/2024
09/22/2024
PER OREM
1tab
BID
UTI Complicated
Waiting Final Action 
03/09/2026
CEFTRIAXONE 1G (VIAL)
03/09/2026
03/15/2026
IV
2gms
OD
Sepsis
Checking Initial Appropriateness 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: